Regulatory Systems in Bone Marrow for Hematopoietic Stem/Progenitor Cells Mobilization and Homing

被引:36
作者
Alvarez, P. [1 ,2 ]
Carrillo, E. [1 ,2 ]
Velez, C. [1 ,2 ]
Hita-Contreras, F. [1 ,3 ]
Martinez-Amat, A. [1 ,3 ]
Rodriguez-Serrano, F. [1 ,2 ]
Boulaiz, H. [1 ,2 ]
Ortiz, R. [1 ,3 ]
Melguizo, C. [1 ,2 ]
Prados, J. [1 ,2 ]
Aranega, A. [1 ,2 ]
机构
[1] Univ Granada, Inst Biopathol & Regenerat Med IBIMER, Granada 18100, Spain
[2] Univ Granada, Sch Med, Dept Human Anat & Embryol, E-18071 Granada, Spain
[3] Univ Jaen, Dept Hlth Sci, Jaen 23071, Spain
关键词
COLONY-STIMULATING FACTOR; BLOOD STEM-CELLS; PLUS G-CSF; NON-HODGKINS-LYMPHOMA; ACUTE MYOCARDIAL-INFARCTION; MULTIPLE-MYELOMA PATIENTS; PERIPHERAL-BLOOD; PROGENITOR CELLS; BIOACTIVE LIPIDS; RAPID MOBILIZATION;
D O I
10.1155/2013/312656
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Regulation of hematopoietic stem cell release, migration, and homing from the bone marrow (BM) and of the mobilization pathway involves a complex interaction among adhesion molecules, cytokines, proteolytic enzymes, stromal cells, and hematopoietic cells. The identification of new mechanisms that regulate the trafficking of hematopoietic stem/progenitor cells (HSPCs) cells has important implications, not only for hematopoietic transplantation but also for cell therapies in regenerative medicine for patients with acute myocardial infarction, spinal cord injury, and stroke, among others. This paper reviews the regulation mechanisms underlying the homing and mobilization of BM hematopoietic stem/progenitor cells, investigating the following issues: (a) the role of different factors, such as stromal cell derived factor-1 (SDF-1), granulocyte colony-stimulating factor (G-CSF), and vascular cell adhesion molecule-1 (VCAM-1), among other ligands; (b) the stem cell count in peripheral blood and BM and influential factors; (c) the therapeutic utilization of this phenomenon in lesions in different tissues, examining the agents involved in HSPCs mobilization, such as the different forms of G-CSF, plerixafor, and natalizumab; and (d) the effects of this mobilization on BM-derived stem/progenitor cells in clinical trials of patients with different diseases.
引用
收藏
页数:12
相关论文
共 138 条
[1]   A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor [J].
Abhyankar, S. ;
DeJarnette, S. ;
Aljitawi, O. ;
Ganguly, S. ;
Merkel, D. ;
McGuirk, J. .
BONE MARROW TRANSPLANTATION, 2012, 47 (04) :483-487
[2]   CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow [J].
Avigdor, A ;
Goichberg, P ;
Shivtiel, S ;
Dar, A ;
Peled, A ;
Samira, S ;
Kollet, O ;
Hershkoviz, R ;
Alon, R ;
Hardan, I ;
Ben-Hur, H ;
Naor, D ;
Nagler, A ;
Lapidot, T .
BLOOD, 2004, 103 (08) :2981-2989
[3]   Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization [J].
Awan, Farrukh T. ;
Kochuparambil, S. Thomas ;
DeRemer, David ;
Cumpston, Aaron ;
Craig, Michael ;
Jillella, Anand ;
Hamadani, Mehdi .
JOURNAL OF ONCOLOGY, 2012, 2012
[4]   The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J].
Balabanian, K ;
Lagane, B ;
Infantino, S ;
Chow, KYC ;
Harriague, J ;
Moepps, B ;
Arenzana-Seisdedos, F ;
Thelen, M ;
Bachelerie, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) :35760-35766
[5]   The EBMT activity survey 2009: trends over the past 5 years [J].
Baldomero, H. ;
Gratwohl, M. ;
Gratwohl, A. ;
Tichelli, A. ;
Niederwieser, D. ;
Madrigal, A. ;
Frauendorfer, K. .
BONE MARROW TRANSPLANTATION, 2011, 46 (04) :485-501
[6]  
Becker P S, 1997, Biol Blood Marrow Transplant, V3, P45
[7]   FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS [J].
BENSINGER, W ;
APPELBAUM, F ;
ROWLEY, S ;
STORB, R ;
SANDERS, J ;
LILLEBY, K ;
GOOLEY, T ;
DEMIRER, T ;
SCHIFFMAN, K ;
WEAVER, C ;
CLIFT, R ;
CHAUNCEY, T ;
KLARNET, J ;
MONTGOMERY, P ;
PETERSDORF, S ;
WEIDEN, P ;
WITHERSPOON, R ;
BUCKNER, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2547-2555
[8]   Improving stem cell mobilization strategies: future directions [J].
Bensinger, W. ;
DiPersio, J. F. ;
McCarty, J. M. .
BONE MARROW TRANSPLANTATION, 2009, 43 (03) :181-195
[9]   Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab [J].
Bonig, Halvard ;
Wundes, Annette ;
Chang, Kai-Hsin ;
Lucas, Sylvia ;
Papayannopoulou, Thalia .
BLOOD, 2008, 111 (07) :3439-3441
[10]   Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC [J].
Bonig, Halvard ;
Priestley, Gregory V. ;
Oehler, Vivian ;
Papayannopoulou, Thalia .
EXPERIMENTAL HEMATOLOGY, 2007, 35 (02) :326-334